NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Monday that it plans to offer $250 million aggregate principal amount of convertible senior notes due 2021.

The notes will be offered and sold to qualified institutional buyers. The Sunnyvale, Calif.-based firm added that it intends to grant the notes' initial purchasers the option to purchase up to $37.5 million amount of notes to cover any overallotments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.

With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.

In a series of articles, medical journals debate the necessity of conflict-of-interest policies.

Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.